BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Enzon Incorporated

Enzon Incorporated is a biopharmaceutical company that develops, manufactures and markets enhanced therapeutics for life-threatening diseases through the application of its two proprietary technologies: (i) polyethylene glycol ("PEG") Modification or the PEG Process and (ii) single-chain antigen-binding ("SCA(R)") proteins. Enzon is focusing its internalresearch activities on applying its proprietary technologies to compounds of known therapeutic efficacy in order to enhance the performance of these compounds. Enzon is commercializing its proprietary technologies by developing products internally and in cooperation with strategic partners. To date, Enzon and its partners have successfully commercialized two products, ONCASPAR(R) and ADAGEN(R).


Contact Details:
20 Kingsbridge Road
Piscataway
NJ
08854
United States of America
Tel:732 980 4500
Fax:732 980 5911
Email:
WWW:

www.enzon.com/




Loading...

Recent Publications by Enzon Incorporated:

Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model.
PURPOSE: Clinical development of SN38, the active metabolite of...
21st May, 2008
Enzon Pharmaceuticals, Inc., Piscataway, New Jersey 08854, USA. Clin Cancer Res. 2008 Mar 15;14(6):1888-96.
DOI Direct Link
Releasable PEGylation of proteins with customized linkers.
Releasable PEGylation employs customized linkers that reversibly tether a...
6th May, 2008
Enzon Pharmaceuticals, Inc., 20 Kingsbridge Road, Piscataway, New Jersey Adv Drug Deliv Rev. 2008 Jan 3;60(1):29-49. Epub 2007 Aug 16.
DOI Direct Link
Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers.
CPT-11, also known as irinotecan, is a prodrug that is approved for the...
29th March, 2008
Enzon Pharmaceuticals, Inc., 20 Kingsbridge Road, Piscataway, New Jersey Bioconjug Chem. 2008 Apr;19(4):849-59. Epub 2008 Mar 28.
DOI Direct Link
Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in mice.
Recombinant immunotoxins exhibit targeting and cytotoxic functions needed...
30th August, 2007
Enzon Pharmaceuticals, Incorporated, 20 Kingsbridge Road, Piscataway, New Bioconjug Chem. 2007 May-Jun;18(3):773-84. Epub 2007 Mar 9.
DOI Direct Link
Antibody engineering and modification technologies.
Antibody engineering has become a well-developed discipline, encompassing...
27th July, 2007
Enzon Pharmaceuticals, Piscataway, NJ 08854-3969, USA. Biomol Eng. 2007 Jun;24(2):201-15. Epub 2007 Mar 31.
DOI Direct Link

View more Enzon Incorporated research publications.

BioNews Results for Enzon Incorporated:

High Growth Reported for the World Blood Banking & Blood Products Market
SkyNewswire.com:  Jun 29 2008 9:46PM Matching: enzon
Biotech Back From The Dead
Yahoo!:  Jun 27 2008 4:24PM Matching: enzon
High Growth Reported for the World Blood Banking & Blood Products Market
Market Wire:  Jun 27 2008 9:50PM Matching: enzon
ValuEngine Upgrades Brasil Telecom, Enzon Pharma To A 5 Rating
TMC Net:  Jun 25 2008 7:02AM Matching: enzon
ValuEngine Upgrades Brasil Telecom, Enzon Pharma To A 5 Rating
Calibre Macro World:  Jun 25 2008 3:38AM Matching: enzon
Promote your company here: BioNewsCast - Press Release Distribution

View more Enzon Incorporated news.

Enzon Incorporated Patents:

US Patent No.Title
5990275 Linker and linked fusion polypeptides
6180095 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
6194580 High yield method for stereoselective acylation of tertiary alcohols
6214330 Coumarin and related aromatic-based polymeric prodrugs
6251382 Biodegradable high molecular weight polymeric linkers and their conjugates

View more Enzon Incorporated patents.

Enzon Incorporated (ENZN) Financial information Links from Barchart

ENZN Quote from from Barchart.com
ENZN Chart from from Barchart.com
ENZN Profile from from Barchart.com
ENZN Opinion from from Barchart.com

View more Enzon Incorporated finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 19 individuals from Enzon Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 475 times since April 2007, the link to the organisation's website has been followed 81 times

Recent Search Terms used to find this page: enzon single chain | 20 Kingsbridge Road Piscataway NJ 08854 us | Enzon pharmaceuticals fax number | enzon pharmaceuticals purchase biomol | dr. jack geltosky | enzon contact details | Enzon Pharmaceuticals Corp. | t | enzon nj | Piscataway 20 Kingsbridge | .

Search for more companies in Piscataway

Search for more companies in NJ



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Enzon Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.